B-cell variant of mouse T200 (Ly-5): evidence for alternative mRNA splicing.
AUTOR(ES)
Thomas, M L
RESUMO
The complete cDNA sequence of mouse T200 glycoprotein from the pre-B-cell line 70Z/3 has been determined. The deduced protein sequence differs from that previously reported for a T-cell form of the molecule [Saga, Y., Tung, J.-S., Shen, F.-W. & Boyse, E. A. (1986) Proc. Natl. Acad. Sci. USA 83, 6940-6944] by the insertion of 139 amino acid residues in the amino-terminal region of the molecule. RNA transfer blotting using a cDNA probe encoding this sequence established that the predominant T200 mRNA species from B cells and cytotoxic T-cell clones but not T-helper cell clones or thymocytes contain all or part of the insert. Overlapping genomic clones of murine T200 were isolated and analysis of the intron-exon structure at the 5' end of the gene provides evidence that variants of T200 glycoprotein are generated by alternative mRNA splicing.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=298855Documentos Relacionados
- Human growth hormone DNA sequence and mRNA structure: possible alternative splicing.
- Cloned murine T200 (Ly-5) cDNA reveals multiple transcripts within B- and T-lymphocyte lineages.
- Molecular structure of the human argininosuccinate synthetase gene: occurrence of alternative mRNA splicing.
- Evidence from complementation assays in vitro that U5 snRNP is required for both steps of mRNA splicing.
- Platelet-derived growth factor A chain: gene structure, chromosomal location, and basis for alternative mRNA splicing.